Interview with Randy Goldsmith of Rapamycin Holdings
In this episode, Hall T. Martin conducts an interview with Randy Goldsmith, founder and director of Rapamycin Holdings. Rapamycin Holdings is a San Antonio-based company that is developing and commercializing a patented oral formulation of Rapamycin for the prevention of cancer progression and recurrence. Hall and Randy discuss his background in the industry. They also discuss the FDA process and challenges as well as measuring progress.
You can find Rapamycin Holdings at http://rapamycinholdings.com/
Randy can be reached on LinkedIN at https://www.linkedin.com/in/randy-goldsmith-387aa35/
For more information about Investor Connect or Hall T. Martin, please visit the site at: www.InvestorConnect.org.
Copyright (c) 2017, Hall Martin and investorconnect.org. All rights reserved.
NOTE: Investor Connect is a program under the Texas Open Angel Network which is a 501(c3) non-profit dedicated to the education around startup funding. Hall Martin is the principal contact, and he may be reached at http://www.investorconnect.org/contact.